CD8A and influenza: Harnessing iNKT cell functions holds considerable promise for improving vaccines, including for influenza, because they can be specifically and globally activated using glycolipid antigens to provide a universal form of T cell help that boosts peptide-specific CD8+ T cell and antibody responses.